No connection

Search Results

SIGA vs SLN

SIGA
SIGA Technologies, Inc.
BEARISH
Price
$4.76
Market Cap
$341.0M
Sector
Healthcare
AI Confidence
85%
SLN
Silence Therapeutics plc
BEARISH
Price
$7.53
Market Cap
$355.7M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
SIGA
14.88
SLN
--
Forward P/E
SIGA
3.24
SLN
-10.46
P/B Ratio
SIGA
1.71
SLN
5.71
P/S Ratio
SIGA
3.61
SLN
636.26
EV/EBITDA
SIGA
7.7
SLN
-12.02

Profitability

Gross Margin
SIGA
47.49%
SLN
61.54%
Operating Margin
SIGA
-250.38%
SLN
-37150.0%
Profit Margin
SIGA
24.62%
SLN
0.0%
ROE
SIGA
11.23%
SLN
-90.27%
ROA
SIGA
6.39%
SLN
-30.79%

Growth

Revenue Growth
SIGA
-95.3%
SLN
-99.9%
Earnings Growth
SIGA
--
SLN
--

Financial Health

Debt/Equity
SIGA
0.0
SLN
0.0
Current Ratio
SIGA
11.83
SLN
8.72
Quick Ratio
SIGA
8.79
SLN
8.06

Dividends

Dividend Yield
SIGA
--
SLN
--
Payout Ratio
SIGA
0.0%
SLN
0.0%

AI Verdict

SIGA BEARISH

SIGA presents a stark contrast between a pristine balance sheet and a collapsing operational core, evidenced by a Piotroski F-Score of 4/9 (Stable). While the company maintains zero debt and an exceptional current ratio of 11.83, the YoY revenue decline of -95.30% and an operating margin of -250.38% indicate a severe crisis in business continuity. The current price of $4.76 trades at a premium to both the Graham Number ($4.47) and the Intrinsic Value ($2.24), suggesting the stock is overvalued relative to its fundamentals. Technical trends are fully bearish, and the earnings track record shows a consistent failure to meet analyst expectations.

Strengths
Zero debt (Debt/Equity: 0.00)
Extremely high liquidity (Current Ratio: 11.83)
Strong gross margins (47.49%)
Risks
Catastrophic revenue collapse (-95.30% YoY)
Severe operating losses (Operating Margin: -250.38%)
Consistent earnings misses (0/4 beats in last 4 quarters)
SLN BEARISH

SLN exhibits severe fundamental distress, highlighted by a Piotroski F-Score of 1/9, indicating critical financial weakness. The company has experienced a catastrophic revenue collapse of -99.90% YoY, rendering traditional valuation metrics like the P/S ratio (636.26) meaningless. While the current ratio of 8.72 suggests a temporary liquidity cushion, the operating margin of -37,150% and negative ROE of -90.27% signal an unsustainable burn rate. The recent price surge is entirely decoupled from financial performance and appears purely speculative.

Strengths
High current ratio (8.72) providing short-term liquidity
Zero debt (Debt/Equity 0.00) reducing insolvency risk from leverage
Positive gross margin (61.54%) suggesting potential for product viability
Risks
Near-total collapse of revenue (-99.90% YoY)
Extreme operational inefficiency (Operating Margin -37,150%)
Critical financial health score (Piotroski 1/9)

Compare Another Pair

SIGA vs SLN: Head-to-Head Comparison

This page compares SIGA Technologies, Inc. (SIGA) and Silence Therapeutics plc (SLN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile